GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (LTS:0QQD) » Definitions » Stock Based Compensation

Zimmer Biomet Holdings (LTS:0QQD) Stock Based Compensation : CHF90 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Zimmer Biomet Holdings Stock Based Compensation?

Zimmer Biomet Holdings's Stock Based Compensation for the three months ended in Dec. 2023 was CHF22 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was CHF90 Mil.


Zimmer Biomet Holdings Stock Based Compensation Historical Data

The historical data trend for Zimmer Biomet Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Stock Based Compensation Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.83 65.56 70.00 97.82 86.31

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.97 23.14 30.52 14.03 21.88

Zimmer Biomet Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF90 Mil.


Zimmer Biomet Holdings Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (LTS:0QQD) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings (LTS:0QQD) Headlines

No Headlines